Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −4 vs. Q4 2023
- Shares held
- 17.3M
- −296.5K (−1.7%) vs. Q4 2023
- Total value
- $90.8M
- +$839.3K (+0.9%) vs. Q4 2023
- New holders
- 7
- 12 more added
- Sold out
- 11
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 2,676,580 | $14.1M | 1.12% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $10.6M | 0.29% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,858,735 | $9.81M | 1.53% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,793,166 | $9.47M | 0.00% | −41,346−2.3% | Reduced |
| StemPoint Capital LP | 1,848,582 | $9.29M | 2.48% | +58,400+3.3% | Added |
| Commodore Capital LP | 1,575,000 | $8.32M | 0.56% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,517,696 | $8.01M | 0.79% | −299,034−16.5% | Reduced |
| Sphera Funds Management Ltd. | 808,550 | $4.27M | 0.69% | 00.0% | Unchanged |
| Citadel Advisors LLC | 743,920 | $3.93M | 0.00% | +425+0.1% | Added |
| Armistice Capital, LLC | 364,000 | $1.92M | 0.05% | −114,000−23.8% | Reduced |
| BlackRock Inc. | 348,438 | $1.84M | 0.00% | +1,755+0.5% | Added |
| Susquehanna International Group, LLP | 288,885 | $1.53M | 0.00% | +288,885 | New |
| Geode Capital Management, LLC | 279,482 | $1.48M | 0.00% | +5,010+1.8% | Added |
| Goldman Sachs Group Inc | 166,164 | $877.3K | 0.00% | +2,376+1.5% | Added |
| BML Capital Management, LLC | 150,000 | $792.0K | 0.53% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 144,386 | $762.4K | 0.00% | −47,673−24.8% | Reduced |
| Renaissance Technologies LLC | 109,800 | $580.0K | 0.00% | +109,800 | New |
| ADAR1 Capital Management, LLC | 89,938 | $474.9K | 0.13% | −155,564−63.4% | Reduced |
| State Street Corp | 83,708 | $442.0K | 0.00% | +34,200+69.1% | Added |
| AdvisorShares Investments LLC | 72,071 | $380.5K | 0.06% | +17,760+32.7% | Added |
| Blair William & Co | 68,466 | $361.5K | 0.00% | −19,580−22.2% | Reduced |
| Northern Trust Corp | 50,018 | $264.1K | 0.00% | +1,179+2.4% | Added |
| Millennium Management LLC | 36,498 | $192.7K | 0.00% | +36,498 | New |
| Citigroup Inc | 34,906 | $184.3K | 0.00% | −23,471−40.2% | Reduced |
| Acadian Asset Management LLC | 32,291 | $169.0K | 0.00% | +32,291 | New |
| Charles Schwab Investment Management Inc | 23,302 | $123.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 23,077 | $121.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 21,459 | $113.3K | 0.00% | +1,885+9.6% | Added |
| American Century Companies Inc | 20,331 | $107.3K | 0.00% | +20,331 | New |
| ExodusPoint Capital Management, LP | 18,443 | $97.0K | 0.00% | +18,443 | New |
| Advisor Group Holdings, Inc. | 11,660 | $61.6K | 0.00% | +1,194+11.4% | Added |
| Bank of America Corp | 10,129 | $53.5K | 0.00% | −9,270−47.8% | Reduced |
| GPS Wealth Strategies Group, LLC | 8,441 | $44.6K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 4,736 | $25.0K | 0.00% | +4,619+3,947.9% | Added |
| Tower Research Capital LLC (TRC) | 3,444 | $18.2K | 0.00% | −5,854−63.0% | Reduced |
| CWM, LLC | 2,416 | $13.0K | 0.00% | −33−1.3% | Reduced |
| BFSG, LLC | 1,000 | $5.28K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 211 | $1.11K | 0.00% | +3+1.4% | Added |
| Farther Finance Advisors, LLC | 81 | $437 | 0.00% | +81 | New |
| Jones Financial Companies LLLP | 80 | $422 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $153 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $84 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −96,900−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −41,886−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,940−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,524−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −15,171−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −12,371−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,437−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |